Arie Gruzman was born in Gorky, USSR in 1970. He graduated from First Nurse College, Gorky, USSR at 1988 (Practical Nursing, Summa cum Laude). After then, he started studying in Medical Institute, Gorky, USSR (MD). The study was interrupted in third year due to repatriation to Israel. He obtained his B.Sc. in Medicinal Chemistry from Bar-Ilan University, Ramat-Gan, Israel, at 1996. He obtained direct Ph.D. (Summa cum Laude) in pharmacology under supervision of Prof. S. Sasson, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel at 2003. After then he moved to USA, where he was trained as a post doctorate fellow at University of California, San Francisco & Research Institute of Pacific Medical Center at San Francisco, under supervision of Prof. V. Lingappa. Since 2009, he is a faculty member at Department of Chemistry, Bar-Ilan University, Israel. From 2011 until 2015 he was served as a Vice-President of Israel Association of Medicinal Chemistry. He was elected as Israeli Representative of the Chemistry and Human Health, Division of International Union of Pure and Applied Chemistry (IUPAC) for the term 2022–2023. He is also one of the founders of the startup drug development company “AltA-ZuZ”. His research group aims to develop new drug candidates against several devastating human diseases, such as ALS, autoimmune diseases, diabetes type 2 and retinopathies.